MDIHX
Price
$28.64
Change
+$0.91 (+3.28%)
Updated
Feb 3 closing price
Net Assets
45.76B
RLIEX
Price
$19.90
Change
-$0.29 (-1.44%)
Updated
Feb 3 closing price
Net Assets
1.27B
Interact to see
Advertisement

MDIHX vs RLIEX

Header iconMDIHX vs RLIEX Comparison
Open Charts MDIHX vs RLIEXBanner chart's image
MFS Intl Diversification R3
Price$28.64
Change+$0.91 (+3.28%)
VolumeN/A
Net Assets45.76B
Lazard International Equity R6
Price$19.90
Change-$0.29 (-1.44%)
VolumeN/A
Net Assets1.27B
MDIHX vs RLIEX Comparison Chart in %
View a ticker or compare two or three
VS
MDIHX vs. RLIEX commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDIHX is a Hold and RLIEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MDIHX has more cash in the bank: 45.8B vs. RLIEX (1.27B). RLIEX pays higher dividends than MDIHX: RLIEX (2.23) vs MDIHX (1.93). MDIHX was incepted earlier than RLIEX: MDIHX (21 years) vs RLIEX (11 years). MDIHX (1.10) is less costly to investors than RLIEX (0.85). RLIEX is a more actively managed with annual turnover of: 41.00 vs. MDIHX (2.00). MDIHX has a lower initial minimum investment than RLIEX: MDIHX (0) vs RLIEX (1000000). MDIHX annual gain was more profitable for investors over the last year : 27.33 vs. RLIEX (23.93). MDIHX return over 5 years is better than : 31.08 vs. RLIEX (16.36).
MDIHXRLIEXMDIHX / RLIEX
Total Expense Ratio1.080.80135%
Annual Report Gross Expense Ratio1.100.85129%
Fund Existence21 years11 years-
Gain YTD5.5666.41787%
Front LoadN/AN/A-
Min. Initial Investment01000000-
Min. Initial Investment IRAN/AN/A-
Net Assets45.8B1.27B3,606%
Annual Yield % from dividends1.932.2386%
Returns for 1 year27.3323.93114%
Returns for 3 years42.3837.64113%
Returns for 5 years31.0816.36190%
Returns for 10 years137.0051.90264%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KYMR77.221.60
+2.12%
Kymera Therapeutics
FVCB15.600.09
+0.58%
FVCBankcorp
NVCR11.84-0.35
-2.87%
NovoCure Limited
THH0.67-0.05
-6.65%
Tryhard Holdings Limited
SPGI468.21-59.45
-11.27%
S&P Global